Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in the food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northfield, Illinois.
IPO Year:
Exchange: NYSE
Website: stepan.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/19/2023 | $89.00 | Neutral → Buy | CL King |
| 3/11/2022 | $9.00 → $8.00 | Outperform | RBC Capital |
| 12/20/2021 | $8.50 → $9.00 | Outperform | RBC Capital |
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
3 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
4 - STEPAN CO (0000094049) (Issuer)
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.7%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.385 per share is payable on December 13, 2024, to common stockholders of record on November 29, 2024. The increase marks the 57th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemic
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2024 Highlights Reported net income was $23.6 million, up 88% versus prior year. Adjusted net income(1) was $23.7 million, up 61% versus prior year, largely due to higher margins and a lower effective tax rate. The year-over-year change in effective tax rate positively impacted net income by $6.8 million, or $0.30 per diluted share.EBITDA(2) was $53.0 million and Adjusted EBITDA(2) was $53.1 million, up 18% and 11% respectively, year-over-year.Global sales volume was down 1%
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,
NORTHBROOK, Ill., Oct. 9, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its third quarter 2024 earnings results on Wednesday, October 30, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E.
NORTHBROOK, Ill., July 31, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Second Quarter 2024 Highlights Reported net income was $9.5 million, down 25% versus prior year. Adjusted net income(1) was $9.4 million, down 22% versus prior year, largely due to a higher effective tax rate in 2024.Pre-tax earnings were negatively impacted by $18.9 million due to higher operating costs at our Millsdale site, primarily related to a flood event ($11.8 million), pre-commissioning expenses at our new Alkoxylation investment in Pasadena, Texas ($3.6 million) and expenses rel
NORTHBROOK, Ill., July 31, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.375 per share. The dividend is payable on September 13, 2024, to common stockholders of record on August 30, 2024. The Company increased its quarterly cash dividend in the fourth quarter of 2023 by $0.010 per share, marking the 56th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of s
NORTHBROOK, Ill., July 10, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its second quarter 2024 earnings results on Wednesday, July 31, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E.
NORTHBROOK, Ill., April 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.375 per share. The dividend is payable on June 14, 2024, to common stockholders of record on May 31, 2024. The Company increased its quarterly cash dividend in the fourth quarter of 2023 by $0.010 per share, marking the 56th consecutive year that the Company has increased its cash dividend to stockholders. Corporate ProfileStepan Company is a major manufacturer of specialty
NORTHBROOK, Ill., April 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: First Quarter 2024 Highlights Reported net income was $13.9 million. Adjusted net income(1) was $14.7 million, down 11% year-over-year, largely due to a higher effective tax rate in 2024.EBITDA(2) was $50.2 million. Adjusted EBITDA(2) was $51.2 million, up 5% year-over-year.Global sales volume was up 1% year-over-year. Global sales volume, excluding declines in our Agricultural and commodity Phthalic Anhydride businesses, was up 4%.Cash from Operations was $41.6 million during the quarte
NORTHBROOK, Ill., April 9, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its first quarter 2024 earnings results on Tuesday, April 30, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 8:00 a.m. ET (7:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E. Rojo, Vice President and Chief Financial Officer. The call can be accessed by phone and webcast. To access the call by
10-Q - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
10-Q - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
SD - STEPAN CO (0000094049) (Filer)
10-Q - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
8-K - STEPAN CO (0000094049) (Filer)
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.7%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.385 per share is payable on December 13, 2024, to common stockholders of record on November 29, 2024. The increase marks the 57th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemic
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2024 Highlights Reported net income was $23.6 million, up 88% versus prior year. Adjusted net income(1) was $23.7 million, up 61% versus prior year, largely due to higher margins and a lower effective tax rate. The year-over-year change in effective tax rate positively impacted net income by $6.8 million, or $0.30 per diluted share.EBITDA(2) was $53.0 million and Adjusted EBITDA(2) was $53.1 million, up 18% and 11% respectively, year-over-year.Global sales volume was down 1%
NORTHBROOK, Ill., Oct. 9, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its third quarter 2024 earnings results on Wednesday, October 30, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E.
NORTHBROOK, Ill., July 31, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Second Quarter 2024 Highlights Reported net income was $9.5 million, down 25% versus prior year. Adjusted net income(1) was $9.4 million, down 22% versus prior year, largely due to a higher effective tax rate in 2024.Pre-tax earnings were negatively impacted by $18.9 million due to higher operating costs at our Millsdale site, primarily related to a flood event ($11.8 million), pre-commissioning expenses at our new Alkoxylation investment in Pasadena, Texas ($3.6 million) and expenses rel
NORTHBROOK, Ill., July 31, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.375 per share. The dividend is payable on September 13, 2024, to common stockholders of record on August 30, 2024. The Company increased its quarterly cash dividend in the fourth quarter of 2023 by $0.010 per share, marking the 56th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of s
NORTHBROOK, Ill., July 10, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its second quarter 2024 earnings results on Wednesday, July 31, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E.
NORTHBROOK, Ill., April 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.375 per share. The dividend is payable on June 14, 2024, to common stockholders of record on May 31, 2024. The Company increased its quarterly cash dividend in the fourth quarter of 2023 by $0.010 per share, marking the 56th consecutive year that the Company has increased its cash dividend to stockholders. Corporate ProfileStepan Company is a major manufacturer of specialty
NORTHBROOK, Ill., April 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: First Quarter 2024 Highlights Reported net income was $13.9 million. Adjusted net income(1) was $14.7 million, down 11% year-over-year, largely due to a higher effective tax rate in 2024.EBITDA(2) was $50.2 million. Adjusted EBITDA(2) was $51.2 million, up 5% year-over-year.Global sales volume was up 1% year-over-year. Global sales volume, excluding declines in our Agricultural and commodity Phthalic Anhydride businesses, was up 4%.Cash from Operations was $41.6 million during the quarte
NORTHBROOK, Ill., April 9, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its first quarter 2024 earnings results on Tuesday, April 30, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 8:00 a.m. ET (7:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E. Rojo, Vice President and Chief Financial Officer. The call can be accessed by phone and webcast. To access the call by
NORTHBROOK, Ill., Feb. 20, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Fourth Quarter Highlights The Company incurred a reported net loss of $1.2 million, or negative $0.05 per diluted share, versus $10.8 million of reported net income, or $0.47 per diluted share, in the prior year. Adjusted net income* was $7.5 million, or $0.33 per diluted share, versus $13.5 million, or $0.59 per diluted share, in the prior year. Total Company sales volume increased 3% versus the prior year.Surfactant operating income was $14.8 million versus $21.8 million in the prior year. This decrease was primarily due to lower unit margins that were partially offset by a 1% increase in global s
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,
NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024. Ms. Lewis spent over 30 years at Dow Inc., a materials science company, and was part of the management team of Corteva, Inc., a global agriculture company, following its spinoff from DowDuPont Inc. Ms. Lewis served as Senior Vice President, Global Operations of Corteva from 2018 until her retirement in 2021, after which she worked as a business and executive consultant through 2023. Ms. Lewis held senior management roles with operations, sustainability and risk management responsibilities and led organizational r
VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))) ("AVITA Medical"), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors effective July 1, 2021. Mr. Corbett has approximately 40 years of leadership experience in the medical device field, most recently, as CEO of CathWorks Ltd., a software-based medical technology company. Mr. Corbett has extensive global commercial and operating experience, serving as an
NORTHFIELD, Ill., Jan. 27, 2021 /PRNewswire/ -- Stepan Company (NYSE: SCL) today announced the appointment of Lorinda Burgess as a director of the Company, effective on January 27, 2021. Ms. Burgess currently serves as Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc. In her over 20-year career with Medtronic, Ms. Burgess has held multiple financial leadership positions covering a range of geographies. Prior to joining Medtronic, Ms. Burgess held key finance and investor relations positions with Marshall Field's Corporation and BET Holdings Inc. Ms. Burgess earned a BA in Political Science from the University of Michigan, and an MBA from The Ohio State
CL King upgraded Stepan Company from Neutral to Buy and set a new price target of $89.00
RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $8.00 from $9.00 previously
RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $9.00 from $8.50 previously
SC 13G - STEPAN CO (0000094049) (Subject)
SC 13G/A - STEPAN CO (0000094049) (Subject)
SC 13G/A - STEPAN CO (0000094049) (Subject)
SC 13G/A - STEPAN CO (0000094049) (Subject)
SC 13G/A - STEPAN CO (0000094049) (Subject)
SC 13G - STEPAN CO (0000094049) (Subject)
SC 13G - STEPAN CO (0000094049) (Subject)
SC 13G/A - STEPAN CO (0000094049) (Subject)
"Looking forward, we believe sales volumes will continue to gradually improve due to ongoing recovery in Rigid Polyols and growth in Surfactant volumes including the expected recovery of the Agricultural business in the second half of the year," said Scott Behrens, President and Chief Executive Officer.
Stepan (NYSE:SCL) reported quarterly Adj earnings of $0.64 per share which beat the analyst consensus estimate of $0.35 by 82.86 percent. This is a 9.86 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $551.418 million which missed the analyst consensus estimate of $575.825 million by 4.24 percent. This is a 15.35 percent decrease over sales of $651.436 million the same period last year.
Wednesday marks the last chance for investors to receive the next dividend payout from Stepan (NYSE:SCL). What's Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 37.5 cents per share. On Thursday, Stepan will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 37.5 cents lower than it would have opened on any other day. In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own SCL as of the end of Wednesday's session are eligible to receive the 37.5 cents dividend payout f
Stepan (NYSE:SCL) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.37 by 10.81 percent. This is a 44.07 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $532.13 million which missed the analyst consensus estimate of $534.52 million by 0.45 percent. This is a 15.15 percent decrease over sales of $627.18 million the same period last year.
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. • Fresenius Medical Care (NYSE:FMS) is projected to report quarterly earnings at $0.32 per share on revenue of $5.35 billion. • NexPoint Residential (NYSE:NXRT) is projected to report earnings for its fourth quarter. • Summit Therapeutics (NASDAQ:SMMT) is likely to report earnings for its fourth quarter. • Axsome Therapeutics (NASDAQ:AXSM) is projected to report quarterly loss at $1.15 per share on revenue of $67.69 million. • Gran Tierra Energy (AMEX:GTE) is expected to report quarterly loss at $0.13 per share on revenue of $60 thousand. • O
Stepan (NYSE:SCL) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here's what investors need to know before the announcement. Analysts estimate that Stepan will report an earnings per share (EPS) of $0.37. Stepan bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Historical Earnings Performance Last quarter the company missed EPS by $0.11, which was followed by a 1.63% increase in the share price the nex
Stepan Company (NYSE:SCL) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 20, 2024. Analysts expect the Northbrook, Illinois-based company to report quarterly earnings at 37 cents per share, down from year-ago earnings of 59 cents per share. Stepan is projected to post revenue of $534.53 billion for the latest quarter, compared to $627.18 million in the year-earlier quarter, according to data from Benzinga Pro. Stepan recently announced the appointment of Susan M. Lewis as a director, effective on Feb. 15. During October, the company reported a third-quarter FY23 sales decrease of 22% year-on-year, to $562.226 million, missing the analyst co
As of Dec. 8, 2023, five stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. Ranpak Holdings Corp. (NYSE:PACK) On Oct. 31, Ranpak Hldgs posted a narrower-than-expected third-qua
Upgrades According to CL King, the prior rating for Stepan Co (NYSE:SCL) was changed from Neutral to Buy. In the third quarter, Stepan showed an EPS of $0.64, compared to $2.01 from the year-ago quarter. NoneThe stock has a 52-week-high of $114.79 and a 52-week-low of $63.60. At the end of the last trading period, Stepan closed at $72.21. For Netflix Inc (NASDAQ:NFLX), Keybanc upgraded the previous rating of Sector Weight to Overweight. For the third quarter, Netflix had an EPS of $3.73, compared to year-ago quarter EPS of $3.10. NoneThe stock has a 52-week-high of $485.00 and a 52-week-low of $237.75. At the end of the last trading period, Netflix closed at $346.19. JP Morgan upgraded